Back to Search
STEPHEN KROLL, MD
MD
Otolaryngology/Facial Plastic Surgery Physician
NPI: 1427107150Individual
Specialties, Licenses & Credentials
Otolaryngology/Facial Plastic Surgery PhysicianPrimary
Otolaryngology — Otolaryngology/Facial Plastic Surgery
Code: 207YX0905X
7485(SC)
Plastic Surgery Physician
Plastic Surgery
Code: 208200000X
7485(SC)
Research & Publications (20)
The carboxyl-terminal domain of the granulocyte colony-stimulating factor receptor uncouples ribosomal biogenesis from cell cycle progression in differentiating 32D myeloid cells.
PMID 11598144·J Biol Chem·2001
7-preclinical
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity.
PMID 19638587·Cancer Res·2009
7-preclinical
A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.
PMID 19188061·Eur J Cancer·2009
3-trial
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
PMID 17661038·Cancer Chemother Pharmacol·2008
3-trial
Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement.
PMID 17325895·Leuk Lymphoma·2007
3-trial
Microvascular breast reconstruction in the diabetic patient.
PMID 17255654·Plast Reconstr Surg·2007
8-other
Monitoring of hematological, inflammatory and oxidative reactions to acute oral iron exposure in human volunteers: preliminary screening for selection of potentially-responsive biomarkers.
PMID 15963385·Toxicology·2005
4-observational
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
PMID 16110029·J Clin Oncol·2005
3-trial
Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas.
PMID 16186600·J Clin Oncol·2005
3-trial
Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab.
PMID 16204016·J Clin Oncol·2005
3-trial
Managing knowledge and technology to foster innovation at the Ohio State University Medical Center.
PMID 16249301·Acad Med·2005
8-other
131I-tositumomab therapy as initial treatment for follicular lymphoma.
PMID 15689582·N Engl J Med·2005
3-trial
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
PMID 15731177·Blood·2005
8-other
A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.
PMID 16331761·J Rheumatol·2005
2-rct
Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab.
PMID 15613695·J Clin Oncol·2005
3-trial
The radioisotope contributes significantly to the activity of radioimmunotherapy.
PMID 15585610·Clin Cancer Res·2004
3-trial
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.
PMID 15084620·J Clin Oncol·2004
3-trial
Age dependence of in vitro survival of meningococci in whole blood during childhood.
PMID 14551486·Pediatr Infect Dis J·2003
4-observational
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870.
PMID 12642606·J Exp Med·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 338 HARBISON BLVD
COLUMBIA, SC 29212 - Phone
- (803) 732-6655
Quick Facts
- NPI
- 1427107150
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile